These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23831834)

  • 1. A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells.
    Bhuniya S; Lee MH; Jeon HM; Han JH; Lee JH; Park N; Maiti S; Kang C; Kim JS
    Chem Commun (Camb); 2013 Aug; 49(64):7141-3. PubMed ID: 23831834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
    Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS
    J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modular theranostic prodrug based on a FRET-activated self-immolative linker.
    Redy O; Shabat D
    J Control Release; 2012 Dec; 164(3):276-82. PubMed ID: 22580227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cascade enzymatic reaction activatable gemcitabine prodrug with an AIE-based intracellular light-up apoptotic probe for in situ self-therapeutic monitoring.
    Han H; Teng W; Chen T; Zhao J; Jin Q; Qin Z; Ji J
    Chem Commun (Camb); 2017 Aug; 53(66):9214-9217. PubMed ID: 28766646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
    Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells.
    Han H; Jin Q; Wang Y; Chen Y; Ji J
    Chem Commun (Camb); 2015 Dec; 51(98):17435-8. PubMed ID: 26468509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of a gemcitabine phosphoramidate prodrug.
    Wu W; Sigmond J; Peters GJ; Borch RF
    J Med Chem; 2007 Jul; 50(15):3743-6. PubMed ID: 17602464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine.
    Vrettos EΙ; Kyrkou SG; Zoi V; Giannakopoulou M; Chatziathanasiadou MV; Kanaki Z; Agalou A; Bistas VP; Kougioumtzi A; Karampelas T; Diamantis DA; Murphy C; Beis D; Klinakis A; Tamvakopoulos C; Kyritsis AP; Alexiou GA; Tzakos AG
    Chemistry; 2024 Sep; 30(50):e202401327. PubMed ID: 38941241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A facile route to heterotelechelic polymer prodrug nanoparticles for imaging, drug delivery and combination therapy.
    Vinciguerra D; Denis S; Mougin J; Jacobs M; Guillaneuf Y; Mura S; Couvreur P; Nicolas J
    J Control Release; 2018 Sep; 286():425-438. PubMed ID: 30099018
    [No Abstract]   [Full Text] [Related]  

  • 12. Folate-based near-infrared fluorescent theranostic gemcitabine delivery.
    Yang Z; Lee JH; Jeon HM; Han JH; Park N; He Y; Lee H; Hong KS; Kang C; Kim JS
    J Am Chem Soc; 2013 Aug; 135(31):11657-62. PubMed ID: 23865715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory-stimuli-responsive turn-on NIR fluorogenic theranostic prodrug: adjuvant delivery of diclofenac and hydrogen sulfide attenuates acute inflammatory disorders.
    Sufian A; Parihar N; Badirujjaman M; Barman P; Kesarwani R; Pemmaraju DB; Bhabak KP
    J Mater Chem B; 2024 May; 12(17):4248-4261. PubMed ID: 38602387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomized tumor-microenvironment-active NIR fluorescent prodrug for ensuring synchronous occurrences of drug release and fluorescence tracing.
    Li Q; Cao J; Wang Q; Zhang J; Zhu S; Guo Z; Zhu WH
    J Mater Chem B; 2019 Mar; 7(9):1503-1509. PubMed ID: 32255021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-gemcitabine: a new gemcitabine prodrug for treating cancer.
    Dasari M; Acharya AP; Kim D; Lee S; Lee S; Rhea J; Molinaro R; Murthy N
    Bioconjug Chem; 2013 Jan; 24(1):4-8. PubMed ID: 23237198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
    Tsume Y; Drelich AJ; Smith DE; Amidon GL
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells.
    Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S
    Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy.
    Han H; Wang H; Chen Y; Li Z; Wang Y; Jin Q; Ji J
    Nanoscale; 2016 Jan; 8(1):283-91. PubMed ID: 26608864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.
    Redy-Keisar O; Ferber S; Satchi-Fainaro R; Shabat D
    ChemMedChem; 2015 Jun; 10(6):999-1007. PubMed ID: 25847527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.